Haleon plc filings document foreign private issuer disclosures for a global consumer health company whose American depositary shares trade under HLN. Form 6-K reports cover current information such as trading statements, ordinary-share repurchases for cancellation, total voting rights and capital, and annual general meeting poll results.
The filing record also includes debt-market disclosures, including listing particulars for the Euro Medium Term Note programme of Haleon UK Capital plc and Haleon Netherlands Capital B.V. guaranteed by Haleon. Governance and capital-structure disclosures address directors' remuneration, board elections, dividend approvals, special resolutions, ordinary shares, treasury shares, voting rights and shareholder notification thresholds.
BlackRock, Inc. filed an amended Schedule 13G reporting beneficial ownership of common stock of Haleon plc. BlackRock reports beneficial ownership of 745,718,619 shares of Haleon common stock, representing 8.5% of the class.
BlackRock has sole voting power over 691,385,758 shares and sole dispositive power over 745,718,619 shares, with no shared voting or dispositive power reported. Various underlying clients or other persons have rights to dividends or sale proceeds from these shares, but no such person is reported to hold more than five percent of Haleon’s outstanding common shares.
Haleon plc reported that Chief Financial Officer Dawn Allen received a vesting of performance-based share awards under the Haleon Performance Share Plan. On 30 June 2026, she acquired 283,193.151771 ordinary shares at nil cost, reflecting achievement of performance conditions through 31 December 2025 and continued employment requirements.
As part of the same event, 133,300.732432 shares were automatically sold on the London Stock Exchange at £3.523867 per share to meet tax liabilities. The remaining shares are subject to Haleon’s shareholding requirements, as well as malus and clawback provisions designed to align executive rewards with long-term performance.
Haleon plc reports its share capital and voting rights position. As at 30 June 2026, the company has issued 8,820,906,422 ordinary shares of £0.01 each, of which 12,006,714 are held as treasury shares. This leaves 8,808,899,708 ordinary shares with voting rights. Shareholders and others with notification obligations are instructed to use this voting-rights figure as the denominator when assessing whether they must notify their interest in Haleon under the FCA's Disclosure Guidance and Transparency Rules.
Haleon plc reports it has purchased 6,992,435 ordinary shares of £0.01 each for cancellation under its share buyback programme announced on 12 March 2026. The purchases were made on 22 and 23 June 2026 across the London Stock Exchange, Cboe UK venues and Aquis at volume weighted average prices around 332–334 pence per share.
After settlement, Haleon’s registered share capital is 8,820,906,422 ordinary shares, including 12,006,714 treasury shares. The number of ordinary shares with voting rights is now 8,808,899,708, which shareholders can use when assessing disclosure thresholds under UK transparency rules.
Haleon plc reported that it purchased 14,288,204 ordinary shares of £0.01 each for cancellation under its share buyback programme announced on 12 March 2026. The shares were bought on several UK trading venues between 15 and 18 June 2026 at volume-weighted average prices around 331–334 pence per share.
After settlement of these transactions, Haleon’s registered share capital is 8,827,898,857 ordinary shares, of which 12,022,709 are held as treasury shares. This leaves 8,815,876,148 ordinary shares with voting rights, a figure shareholders can use to assess whether disclosure thresholds are met under UK transparency rules.
Haleon plc reported that it bought back 565,285 ordinary shares of £0.01 each on 8 June 2026 for cancellation under its share buyback programme announced on 12 March 2026. The shares were purchased on the London Stock Exchange.
The highest price paid was 335.0000p per share, the lowest was 330.5000p, and the volume-weighted average price was 331.9552p. After this transaction, registered share capital is 8,842,187,061 ordinary shares, including 12,025,084 held as treasury shares.
The number of ordinary shares with voting rights is now 8,830,161,977. Haleon notes that shareholders can use this figure when assessing whether they must notify their holdings under the UK Disclosure Guidance and Transparency Rules.
Haleon plc reported recent activity under its share buyback programme, announcing the purchase of 16,585,448 ordinary shares of £0.01 each for cancellation between 1 and 4 June 2026 across the London Stock Exchange, CBOE (UK) venues and Aquis.
Following settlement, Haleon’s registered share capital is 8,842,752,346 ordinary shares, including 12,063,502 treasury shares. The resulting number of ordinary shares with voting rights is 8,830,688,844, a figure shareholders can use when assessing disclosure thresholds under UK transparency rules.
Haleon plc reported its updated share capital and voting rights position. As at 31 May 2026, the company had 8,859,337,794 ordinary shares of £0.01 each in issue, of which 12,076,964 were held as treasury shares.
This leaves 8,847,260,830 ordinary shares with voting rights. Haleon explains that this voting-rights figure should be used by shareholders and other obliged investors as the denominator when calculating whether they must notify holdings or changes in holdings under the FCA’s Disclosure Guidance and Transparency Rules.
Haleon plc reported the purchase and cancellation of 10,149,493 ordinary shares of £0.01 each under its share buyback programme announced on 12 March 2026. The shares were bought on multiple UK trading venues between 26 and 29 May 2026 at prices generally around the mid‑340 pence range.
After these transactions are settled, Haleon’s registered share capital is 8,859,337,794 ordinary shares, of which 12,076,964 are held as treasury shares. This leaves 8,847,260,830 ordinary shares with voting rights, a figure shareholders can use for regulatory disclosure threshold calculations.
Haleon plc reported that it bought back 2,458,291 ordinary shares of £0.01 each for cancellation under its share buyback programme announced on 12 March 2026. Purchases between 18 and 22 May 2026 were made across the London Stock Exchange, CBOE (UK) BXE and CXE.
After settlement, Haleon’s registered share capital is 8,869,487,287 ordinary shares, including 12,092,166 held as treasury shares. The number of ordinary shares with voting rights is now 8,857,395,121, a figure shareholders can use for UK disclosure and transparency notifications.